Stocks and Investing Stocks and Investing
Fri, June 11, 2021
Thu, June 10, 2021

Marc Goodman Maintained (BIIB) at Buy with Increased Target to $475 on, Jun 10th, 2021


Published on 2024-10-27 16:57:18 - WOPRAI, Marc Goodman
  Print publication without navigation


Marc Goodman of SVB Leerink, Maintained "Biogen Inc." (BIIB) at Buy with Increased Target from $380 to $475 on, Jun 10th, 2021.

Marc has made no other calls on BIIB in the last 4 months.



There are 11 other peers that have a rating on BIIB. Out of the 11 peers that are also analyzing BIIB, 6 agree with Marc's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Brian Abrahams of "RBC Capital" Maintained at Hold with Increased Target to $400 on, Tuesday, June 8th, 2021
  • Brian Skorney of "Baird" Upgraded from Sell to Hold and Increased Target to $382 on, Tuesday, June 8th, 2021
  • Carter Gould of "Barclays" Maintained at Hold with Increased Target to $395 on, Tuesday, June 8th, 2021
  • Mohit Bansal of "Citigroup" Upgraded from Strong Sell to Hold and Increased Target to $440 on, Tuesday, June 8th, 2021
  • Laura Chico of "Wedbush" Maintained at Hold with Increased Target to $245 on, Monday, April 12th, 2021
  • Alethia Young of "Cantor Fitzgerald" Maintained at Hold with Decreased Target to $268 on, Wednesday, February 17th, 2021


These are the ratings of the 5 analyists that currently disagree with Marc


  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $452 on, Tuesday, June 8th, 2021
  • Matt Phipps of "William Blair" Upgraded from Hold to Buy on, Tuesday, June 8th, 2021
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $455 on, Tuesday, June 8th, 2021
  • Michael Yee of "Jefferies" Maintained at Strong Buy with Increased Target to $500 on, Tuesday, June 8th, 2021
  • Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $325 on, Tuesday, May 18th, 2021
Contributing Sources